Neogen Corporation (NEOG)

Name: Neogen Corporation Financial Statements
Creator: Quarter Results

Healthcare | Medical Diagnostics Research

Latest reporting period: 2025-11-30

Latest Quarter

2025-11-30

Revenue

$225M

Net Income

-$15.9M

Operating Margin

-2.4%

Free Cash Flow

-$46.4M

Debt / Assets

39.9%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Neogen Corporation (NEOG).
Income Statement (Quarterly)	2025-11-30	2025-08-31	2025-02-28	2024-11-30
Revenue	224,691,000	209,189,000	220,980,000	231,258,000
Cost of Revenue	118,007,000	137,219,000	110,715,000	117,928,000
Gross Profit	106,684,000	71,970,000	110,265,000	113,330,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	107,498,000	105,936,000	100,377,000	104,316,000
Operating Expenses	112,061,000	87,951,000	104,850,000	570,814,000
Operating Income	-5,377,000	-15,981,000	5,415,000	-457,484,000
Interest Expense	14,848,000	16,442,000	17,737,000	18,141,000
Income Before Tax	-20,364,000	43,808,000	-9,727,000	-476,572,000
Income Tax Expense	-4,440,000	7,470,000	1,230,000	-20,290,000
Net Income	-15,924,000	36,338,000	-10,957,000	-456,282,000
Per Share
EPS	-0.07	0.17	-0.05	-2.10
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Neogen Corporation (NEOG).
Income Statement (Annual)	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31
Revenue	894,661,000	924,222,000	822,447,000	527,159,000	468,459,000
Cost of Revenue	473,285,000	460,322,000	416,492,000	284,146,000	253,403,000
Gross Profit	421,376,000	463,900,000	405,955,000	243,013,000	215,056,000
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	399,910,000	382,761,000	342,401,000	167,346,000	124,640,000
Operating Expenses	411,956,000	405,237,000	368,440,000	184,395,000	140,887,000
Operating Income	9,420,000	58,663,000	37,515,000	34,924,000	74,169,000
Interest Expense	71,622,000	73,394,000	55,961,000	1,267,000	0
Income Before Tax	-1,133,110,000	-14,305,000	-22,042,000	60,207,000	75,268,000
Income Tax Expense	-41,066,000	-4,884,000	828,000	11,900,000	14,386,000
Net Income	-1,092,044,000	-9,421,000	-22,870,000	48,307,000	60,882,000
Per Share
EPS	-5.03	-0.04	-0.12	0.45	0.57
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Neogen Corporation (NEOG).
Balance Sheet (Quarterly)	2025-05-31	2024-05-31	2023-05-31	2022-05-31
Assets
Cash and Cash Equivalents	129,004,000	170,611,000	163,240,000	381,051,000
Short Term Investments	0	325,000	82,329,000	336,578,000
Net Receivables	153,384,000	173,005,000	153,253,000	99,674,000
Inventory	190,859,000	189,267,000	133,812,000	122,313,000
Total Current Assets	576,937,000	589,233,000	585,931,000	626,798,000
Property Plant Equipment	356,283,000	291,889,000	198,749,000	110,584,000
Goodwill and Intangibles	2,475,387,000	3,647,285,000	5,374,854,000	363,050,000
Total Assets	3,443,836,000	4,548,833,000	4,554,432,000	992,929,000
Liabilities
Account Payables	79,605,000	83,061,000	76,669,000	34,614,000
Short Term Debt	27,368,000	7,548,000	3,277,000	1,440,000
Total Current Liabilities	174,011,000	154,323,000	145,472,000	77,844,000
Long Term Debt	887,670,000	898,691,000	900,000,000	0
Total Liabilities	1,372,582,000	1,404,691,000	1,420,215,000	105,555,000
Shareholders Equity
Retained Earnings	-536,424,000	555,620,000	565,041,000	587,911,000
Total Shareholders Equity	2,071,254,000	3,144,142,000	3,134,217,000	887,374,000

Balance sheet annual history for Neogen Corporation (NEOG).
Balance Sheet (Annual)	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31
Assets
Cash and Cash Equivalents	129,004,000	170,611,000	163,240,000	381,051,000	75,602,000
Short Term Investments	0	325,000	82,329,000	336,578,000	305,485,000
Net Receivables	153,384,000	173,005,000	153,253,000	99,674,000	91,823,000
Inventory	190,859,000	189,267,000	133,812,000	122,313,000	100,701,000
Total Current Assets	576,937,000	589,233,000	585,931,000	626,798,000	591,451,000
Property Plant Equipment	356,283,000	291,889,000	198,749,000	110,584,000	102,930,000
Goodwill and Intangibles	2,475,387,000	3,647,285,000	5,374,854,000	363,050,000	223,792,000
Total Assets	3,443,836,000	4,548,833,000	4,554,432,000	992,929,000	920,192,000
Liabilities
Account Payables	79,605,000	83,061,000	76,669,000	34,614,000	23,900,000
Short Term Debt	27,368,000	7,548,000	3,277,000	1,440,000	0
Total Current Liabilities	174,011,000	154,323,000	145,472,000	77,844,000	53,599,000
Long Term Debt	887,670,000	898,691,000	900,000,000	0	0
Total Liabilities	1,372,582,000	1,404,691,000	1,420,215,000	105,555,000	79,815,000
Shareholders Equity
Retained Earnings	-536,424,000	555,620,000	565,041,000	587,911,000	539,604,000
Total Shareholders Equity	2,071,254,000	3,144,142,000	3,134,217,000	887,374,000	840,377,000

Cash flow quarterly history for Neogen Corporation (NEOG).
Cash Flow Statement (Quarterly)	2025-05-31	2024-05-31	2023-05-31	2022-05-31
Operating Activities
Net Income	-1,092,044,000	-9,421,000	-22,870,000	48,307,000
Depreciation & Amortization	125,672,000	121,227,000	88,377,000	23,694,000
Stock Based Compensation	17,291,000	13,768,000	10,177,000	7,154,000
Change in Working Capital	-5,932,000	-72,683,000	-22,785,000	-6,422,000
Operating Cash Flow	58,244,000	35,264,000	41,028,000	68,038,000
Investing Activities
Capital Expenditure	-104,595,000	-111,421,000	-65,757,000	-24,429,000
Investments	-104,595,000	-111,421,000	-65,757,000	-24,429,000
Investing Cash Flow	-99,195,000	-29,309,000	201,039,000	-97,229,000
Financing Activities
Debt Repayment	-321,000	0	-100,000,000	0
Common Stock Issued/Repurchased	2,242,000	2,456,000	1,195,000	7,933,000
Dividends Paid	0	0	0	0
Financing Cash Flow	-1,598,000	1,918,000	-118,081,000	6,813,000
Summary
Free Cash Flow	-46,351,000	-76,157,000	-24,729,000	43,609,000
Net Change in Cash	-41,607,000	7,371,000	118,767,000	-31,129,000

Cash flow annual history for Neogen Corporation (NEOG).
Cash Flow Statement (Annual)	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31
Operating Activities
Net Income	-1,092,044,000	-9,421,000	-22,870,000	48,307,000	60,882,000
Depreciation & Amortization	125,672,000	121,227,000	88,377,000	23,694,000	21,041,000
Stock Based Compensation	17,291,000	13,768,000	10,177,000	7,154,000	6,437,000
Change in Working Capital	-5,932,000	-72,683,000	-22,785,000	-6,422,000	-6,631,000
Operating Cash Flow	58,244,000	35,264,000	41,028,000	68,038,000	81,089,000
Investing Activities
Capital Expenditure	-104,595,000	-111,421,000	-65,757,000	-24,429,000	-26,712,000
Investments	-104,595,000	-111,421,000	-65,757,000	-24,429,000	-26,712,000
Investing Cash Flow	-99,195,000	-29,309,000	201,039,000	-97,229,000	-105,564,000
Financing Activities
Debt Repayment	-321,000	0	-100,000,000	0	0
Common Stock Issued/Repurchased	2,242,000	2,456,000	1,195,000	7,933,000	0
Dividends Paid	0	0	0	0	0
Financing Cash Flow	-1,598,000	1,918,000	-118,081,000	6,813,000	33,544,000
Summary
Free Cash Flow	-46,351,000	-76,157,000	-24,729,000	43,609,000	54,377,000
Net Change in Cash	-41,607,000	7,371,000	118,767,000	-31,129,000	9,333,000